Upcoming Event:

Antibody Drug Development Breakfast
Predicting the Clinical Performance
of Antibody-Based and CAR T Therapeutics

17 November, 2022 | 08:30 CET
(Convert this to your time zone)

Join us for a complimentary breakfast in the Diamant room of the InterContinental Barcelona Hotel. Presentations will be given by Drs. James Keck and Jan Terje Andersen highlighting the utility and importance of immune humanized mouse models as translationally-relevant tools for early preclinical drug development.

This is an in-person only event and there will not be an option for virtual attendance.
JAX events are complimentary.
No fees will be charged for registering.

When registering, please use an institutional (e.g. work, university, etc.) email address or contact our event staff to request an exception. Thank you.

UTM_LT_Campaign:

UTM_LT_Content:

UTM_LT_Medium:

UTM_LT_Source:

Evaluation of Safety and Efficacy of Bispecific and CAR T Therapies in Humanized Mice

James G. Keck, Ph.D.

Senior Director, Innovation and Product Development

The Jackson Laboratory

Of Mice and Men - FcRn Biology and Its Implications in a Therapeutic Perspective

Jan Terje Andersen, Ph.D.

Co-founder of Authera, Professor in Biomedical Innovation,

University of Oslo, Oslo University Hospital